Baxter International, Inc. (BAX)
17.79
+0.49
(+2.83%)
USD |
NYSE |
May 18, 16:00
17.80
0.00 (0.00%)
After-Hours: 20:00
Baxter International Research and Development Expense (Quarterly) : 124.00M for March 31, 2026
Research and Development Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Quarterly) Benchmarks
| Becton, Dickinson & Co. | 249.00M |
| ResMed, Inc. | 94.27M |
| ICU Medical, Inc. | 21.28M |
| Intuitive Surgical, Inc. | 361.60M |
| Stryker Corp. | 404.00M |